GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimi Health Corp (XCNQ:OPTI) » Definitions » Treasury Stock

Optimi Health (XCNQ:OPTI) Treasury Stock : C$0.00 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Optimi Health Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Optimi Health's treasury stock for the quarter that ended in Mar. 2024 was C$0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


Optimi Health Treasury Stock Historical Data

The historical data trend for Optimi Health's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimi Health Treasury Stock Chart

Optimi Health Annual Data
Trend Sep20 Sep21 Sep22 Sep23
Treasury Stock
- - - -

Optimi Health Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Optimi Health Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.


Optimi Health Business Description

Traded in Other Exchanges
Address
21 Water Street, Suite 600, Vancouver, BC, CAN, V6B 1A1
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
Executives
Dane Nicholas Stevens Director, Senior Officer
Bryan Edward Safarik Director, Senior Officer
William John Ciprick Senior Officer
Jacob Frederick Safarik Director, Senior Officer
Jonathan Schintler Director
John James Wilson Director
Michael Alan Stier Director